Validity of composite end points in clinical trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15761002.
- Also identified by PMC identifier 554039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?
Medical subject headings
- Endpoint Determination
- Randomized Controlled Trials as Topic